Drug
Contrast agent BR1 clinical trials
A product of Sulfur Hexafluoride; its studies count on that page too.
Keep track of what changes. Save the contrast agent BR1 studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
13 studies that test it; most in 2009 (2)
| Year | Studies |
|---|---|
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2019 | 1 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 4 · Other 9
Bracco Diagnostics, Inc (3) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (2) · Enrico Ammirati (1) · Société Française d'Endoscopie Digestive (1) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS (1) · NaviFUS Corporation (1) · Central Hospital, Nancy, France (1) · Umeå University (1)
Often tested with
Tested in the same studies.
Related medicines
As reviewed, each with the page that says it.
- A dosage form of Sulfur Hexafluoride source
Studies
Open first, then newest update. How each study uses contrast agent BR1 is read from its arms, and is right about nine times in ten.
Testing it · 13
- A Prospective Pivotal Study to Evaluate the Efficacy and Safety of Avastin® Bevacizumab (BEV) With or Without Microbubble-mediated Focused Ultrasound (FUS-MB) Using NaviFUS System in Recurrent Glioblastoma Multiforme PatientsRecruitingPhase 3NaviFUS CorporationNCT06496971Written as Microbubble
- Study of Placental Vascularization Using Contrast UltrasoundRecruitingPhase 3Central Hospital, Nancy, FranceNCT06497959Written as SonoVue
- Liver Cirrhosis Complicated by Clinically Significant Portal HypertensionNot yet recruitingNot applicableFondazione Policlinico Universitario Agostino Gemelli IRCCSNCT07365709Written as SonoVue
- Comparing SonoVue With Sonazoid Using CEUS-LIRADS in HCCStatus unknownPhase 3Second Affiliated Hospital, School of Medicine, Zhejiang UniversityNCT04006275Written as Sonovue and Sonazoid
- Multiparametric Ultrasound Imaging in Prostate CancerStatus unknownNot applicableAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)NCT03101176Written as SonoVue
- SonoVue®-Enhanced Ultrasound (US) Versus Unenhanced US for Focal Liver Lesion CharacterizationCompletedPhase 3Bracco Diagnostics, IncNCT00829413Written as SonoVue®
- Contrast Enhanced Sonothrombolysis and Sonolysis in Stroke - a Swedish Study (CE-5S)TerminatedPhase 3Umeå UniversityNCT03290053Written as SonoVue
- IMaging Della PLAcca CarotideaCompletedPhase 3Enrico AmmiratiNCT03333330Written as Visipaque 320 and SonoVue
- KVUS at Neoadjuvant CTx of Breast CancerStatus unknownPhase 3RWTH Aachen UniversityNCT03385200Written as SonoVue
- SonoVue®-Enhanced Ultrasound Versus Unenhanced US for Focal Liver Lesion CharacterizationCompletedPhase 3Bracco Diagnostics, IncNCT00788697Written as SonoVue-enhanced ultrasound
- Safety of SonoVue on Pulmonary HemodynamicsCompletedPhase 2Bracco Diagnostics, IncNCT01306292Written as SonoVue
- Quantification of Contrast Enhanced Ultrasound (CEUS) in the Detection of Prostate CancerTerminatedNot applicableAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)NCT01481441Written as SonoVue
- Contrast-harmonic Endoscopic Ultrasound (CH-EUS) for the Diagnosis of Pancreatic AdenocarcinomaCompletedNot applicableSociété Française d'Endoscopie DigestiveNCT01765036Written as SonoVue®
Given in every arm · 2 — contrast agent BR1 is usual care beside what is tested
- Ultrasound-enhanced Uptake of Chemotherapy in Patients With Inoperable Pancreatic Ductal AdenocarcinomaCompletedPhase 2St. Olavs HospitalNCT04146441Written as SonoVue
- Ultrasound-enhanced Delivery of Chemotherapy to Patients With Liver Metastasis From Breast- and Colorectal CancerCompletedPhase 1/2St. Olavs HospitalNCT03477019Written as SonoVue
As the comparator · 1 — what is tested is compared with contrast agent BR1
Codes
What other systems call contrast agent BR1 · ClinicalTrials.gg INT004309
- MeSH (NLM) C420843contrast agent BR1One source ClinicalTrials.gov
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C420843 | contrast agent BR1 | One source ClinicalTrials.gov |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.